NGFR and Alzheimer disease: In this study, we show that Ngfr signaling, when activated in the hippocampus of an AD mouse model, reduces reactive gliotic state through suppressing Lcn2/Slc22a17 signaling and enhances pro-neurogenic fate of astroglia.